According to this IFN-β-induced gene signature, Doherty et al. demonstrate that the triple-negative breast cancer (TNBC) patients with this IFN-β metagene signature have an improved survival rate, accompanied by increased tumor-infiltrating lymphocytes and a repressed CSC metagene signature in their tumor tissues. This evidence concerns the gene IFNB1 and triple-negative breast carcinoma.